BLUE
$0.96
Revenue | $12.39Mn |
Net Profits | $-71.73Mn |
Net Profit Margins | -578.85% |
Bluebird Bio, Inc.’s revenue jumped 17353.52% since last year same period to $12.39Mn in the Q3 2023. On a quarterly growth basis, Bluebird Bio, Inc. has generated 79.85% jump in its revenue since last 3-months.
Bluebird Bio, Inc.’s net profit jumped 6.26% since last year same period to $-71.73Mn in the Q3 2023. On a quarterly growth basis, Bluebird Bio, Inc. has generated 1.61% jump in its net profits since last 3-months.
Bluebird Bio, Inc.’s net profit margin jumped 99.46% since last year same period to -578.85% in the Q3 2023. On a quarterly growth basis, Bluebird Bio, Inc. has generated 45.3% jump in its net profit margins since last 3-months.
EPS Estimate Current Quarter | -0.53 |
EPS Estimate Current Year | -0.53 |
Bluebird Bio, Inc.’s earning per share (EPS) estimates for the current quarter stand at -0.53 - a 19.11% jump from last quarter’s estimates.
Bluebird Bio, Inc.’s earning per share (EPS) estimates for the current year stand at -0.53.
Earning Per Share (EPS) | -0.66 |
Bluebird Bio, Inc.’s earning per share (EPS) jumped 29.79% since last year same period to -0.66 in the Q3 2023. This indicates that the Bluebird Bio, Inc. has generated 29.79% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2023-05-09 | -0.37 | 0.21 | 156.76% |
2023-08-08 | -0.72 | -0.67 | 6.94% |
2023-11-07 | -0.67 | -0.66 | 1.49% |